Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: J Pain. 2013 Dec;14(12 0):10.1016/j.jpain.2013.07.018. doi: 10.1016/j.jpain.2013.07.018

Table 6.

Univariate associations between pain with opening, TMJ sounds, and bruxofacets as etiologic risk factors measured categorically and incidence rate of first-onset TMD, OPPERA prospective cohort study, USA (2006–2011)

Putative risk factor Category N Site-adjusted(1) TMD incidence rate (% of people per annum) Study site-adjusted effect(2) Site, demographic adjusted effect(3) P-value Imputed values for loss to follow-up(4) P-value
Pain on unassisted opening 1 or more 959 4.13 1.43 (1.10, 1.84) 1.51 (1.16, 1.96) 0.002 1.56 (1.19, 2.04) 0.001
0 [ref] 1703 2.87
Pain on assisted opening (un-terminated) 1 or more 677 3.81 1.28 (0.94, 1.73) 1.40 (1.03, 1.91) 0.031 1.47 (1.07, 2.00) 0.015
0 [ref] 1387 2.96
Pain on assisted opening (terminated) 1 or more 469 4.50 1.66 (0.80, 3.42) 1.65 (0.80, 3.39) 0.170 1.58 (0.76, 3.26) 0.220
0 [ref] 121 2.66
TMJ palpation sounds: right 1 or more 865 3.61 1.13 (0.86, 1.47) 1.13 (0.86, 1.47) 0.360 1.28 (0.96, 1.68) 0.083
0 [ref] 1834 3.13
TMJ palpation sounds: left 1 or more 924 3.33 1.00 (0.76, 1.30) 0.99 (0.75, 1.29) 0.940 1.01 (0.75, 1.33) 0.950
0 [ref] 1784 3.25
Number of locations with tooth wear (facets) 1 or more 2359 3.22 0.95 (0.66, 1.36) 0.97 (0.67, 1.39) 0.880 1.11 (0.75, 1.62) 0.600
0 [ref] 338 3.34
(1)

Adjusted rates computed using Poisson regression controlling for study site (categorical variable, 4 levels). Estimated rate is for reference study site (University of Buffalo)

(2)

Rate ratio represents relative increase in incidence rate of TMD relative to reference group. Calculated using Cox proportional hazard regression model adjusted for study site (categorical variable, 4 levels).

(3)

As for footnote 2, with additional adjustment for age in years), gender (categorical, 2 levels), race/ethnicity (categorical, 2 levels) and lifetime U.S. residence (categorical, 2 levels)

(4)

As for footnote 3, with inclusion of imputed TMD rates for subjects lost to follow-up and imputed data for values missing at baseline